A study to assess the bioequivalence of dapagliflozin/metformin XR fixed-dose combination tablets in healthy subjects

Trial Identifier:	D1691C00008
Sponsor:	AstraZeneca
NCTID::	NCT02637037
Start Date:	December 2015
Primary Completion Date:	April 2016
Condition:	Other; Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States of America, MD	Baltimore, MD, United States of America, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.